口服对比剂增强胃超声在大规模多中心研究中评估胃部病变
该大规模多中心研究纳入383945例疑似胃部病变患者,比较常规超声、口服对比剂增强胃超声与上消化道内镜的诊断效能。口服对比剂增强胃超声在检测病变部位、大小、数目及范围方面与内镜相似(P > .05)且远优于常规超声(P < .01),对黏膜下异常(<5mm)及邻近结构异常优于内镜(P < .01),但对微小黏膜异常(<5mm)略逊于内镜(P < .05)。结论认为其诊断性能不劣于上消化道内镜,可作为内镜的有用补充。
要点
- 口服对比剂增强胃超声在检测胃部病变部位、大小、数目及范围方面与上消化道内镜相似(P > .05)。
- 对黏膜下异常(<5mm)及手术病理证实的邻近结构异常,口服对比剂增强胃超声优于上消化道内镜(P < .01)。
- 对微小黏膜异常(<5mm),口服对比剂增强胃超声略逊于上消化道内镜(P < .05)。
核心结论
- 口服对比剂增强胃超声在界定胃部病变解剖位置及范围方面优于常规胃超声,诊断性能不劣于上消化道内镜,可作为上消化道内镜的有用补充。
研究设计与样本
- 大规模多中心研究纳入383945例疑似胃部病变患者,均接受完整口服对比剂增强胃超声及内镜评估;两名操作者独立检查且不知晓其他诊断结果;比较常规超声、口服对比剂增强胃超声与上消化道内镜的准确性。
关键影像表现/征象
- 口服对比剂后胃解剖结构及胃部病变形态特征清晰显示。
诊断标准与关键数值
- 口服对比剂增强胃超声检测胃部病变部位、大小、数目及范围的敏感度、特异度、阳性预测值、阴性预测值及准确性与上消化道内镜相似(P > .05),远高于常规超声(P < .01)。
- 检测黏膜下异常(<5mm)及手术病理证实的邻近结构异常,口服对比剂增强胃超声远优于上消化道内镜(P < .01),优于常规超声(P < .05)。
- 检测微小黏膜异常(<5mm),口服对比剂增强胃超声略逊于上消化道内镜(P < .05),远优于常规超声(P < .01)。
临床应用与阅片要点
- 口服对比剂增强胃超声可用于评估胃部病变的部位、大小、数目及范围。
- 口服对比剂增强胃超声可作为上消化道内镜的有用补充。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the diagnostic efficiency of oral contrast-enhanced gastric ultrasonography in the evaluation of gastric lesions, based on large-scale multicenter study.
METHODS: The study enrolled 383,945 patients with suspect gastric lesions who underwent complete oral contrast-enhanced gastric ultrasonography and endoscopic evaluation. Two operators, unaware of the results of other diagnostic procedures, performed each examination independently. The accuracies of conventional ultrasonography, oral contrast-enhanced gastric ultrasonography, and upper gastrointestinal endoscopy were determined.
RESULTS: After oral contrast, the anatomy of the stomach and morphologic features of gastric lesions were clearly visualized. The sensitivities, specificities, positive predictive values, negative predictive values and accuracies of oral contrast-enhanced ultrasonography in detecting the sites, sizes, numbers, and the extent of gastric lesions,were similar to those of upper gastrointestinal endoscopy (P > .05) and far greater than those of conventional ultrasonography (P < .01). Moreover, oral contrast-enhanced ultrasonography was far better than upper gastrointestinal endoscopy (P < .01) and was better than conventional ultrasonography (P < .05) in detecting the submucosal abnormalities (<5mm) and the adjacent structures abnormalities identified in surgical pathology. However, oral contrast-enhanced ultrasonography was a bit poorer than upper gastrointestinal endoscopy (P < .05) and far better than conventional ultrasonography (P < .01) in detecting the minor mucosal abnormalities (<5mm).
CONCLUSION: Oral contrast-enhanced gastric ultrasonography is superior to conventional gastric ultrasonography in defining the anatomic location and extension of gastric lesions. Its diagnostic performance is not worse than upper gastrointestinal endoscopy and it can be used as a useful supplement to upper gastrointestinal endoscopy.
引用
- Zheng XZ, Zhang LJ, Wu XP, et al. Oral Contrast-Enhanced Gastric Ultrasonography in the Assessment of Gastric Lesions: A Large-Scale Multicenter Study. J Ultrasound Med. 2016. PMID: 27943376. doi:10.7863/ultra.16.01053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。